Fmoc-His(Trt)-OH

Suppliers

Names

[ CAS No. ]:
109425-51-6

[ Name ]:
Fmoc-His(Trt)-OH

[Synonym ]:
MFCD00043332
N-Fmoc-N'-Trityl-L-Histidine
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-trityl-L-histidine
N-alpha-FMOC-N-Trityl-L-histidine
EINECS 439-640-4
Nα-Fmoc-N(im)-trityl-L-histidine
Na-Fmoc-Nim-trityl-L-histidine
Fmoc-His(Trt)-OH
Nα-[(9H-Fluoren-9-ylMethoxy)carbonyl]-tele-(triphenylMethyl)-L-histidine
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1-tritylimidazol-4-yl)propanoic acid
L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-
Nα-Fmoc-τ-trityl-L-histidine
Nα-[(9H-Fluoren-9-ylmethoxy)carbonyl]-τ-(triphenylmethyl)-L-histidine

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
811.7±65.0 °C at 760 mmHg

[ Melting Point ]:
150-155 °C(lit.)

[ Molecular Formula ]:
C40H33N3O4

[ Molecular Weight ]:
619.708

[ Flash Point ]:
444.7±34.3 °C

[ Exact Mass ]:
619.247131

[ PSA ]:
93.45000

[ LogP ]:
8.03

[ Vapour Pressure ]:
0.0±3.1 mmHg at 25°C

[ Index of Refraction ]:
1.657

[ Storage condition ]:
2-8°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
26

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Fmoc-Osu
  • H-His(Trt)-OH
  • 9-Fluorenylmethyl chloroformate

DownStream

  • H-His(Trt)-OH
  • Copper Peptide
  • Angiotensin I/II (4-8)
  • Endothelin (16-21) trifluoroacetate salt

Articles

Chemical synthesis of a polypeptide backbone derived from the primary sequence of the cancer protein NY-ESO-1 enabled by kinetically controlled ligation and pseudoprolines.

Biopolymers 104 , 116-27, (2015)

The cancer protein NY-ESO-1 has been shown to be one of the most promising vaccine candidates although little is known about its cellular function. Using a chemical protein strategy, the 180 amino aci...

New amphiphilic N-phosphoryl oligopeptides designed for gene delivery.

Int. J. Pharm. 468(1-2) , 83-90, (2014)

Gene therapy is a potent tool for the treatment of cancer and other gene defect diseases, which involves using DNA that encodes a functional, therapeutic gene to replace a mutated gene. However, the D...


More Articles

Related Compounds

  • Fmoc-His(Trt)-OH-15N3
  • Fmoc-His(Trt)-Gly-OH
  • Fmoc-His(Trt)-OPFP
  • Fmoc-D-His(Trt)-OH
  • Fmoc-N-Me-His(Trt)-OH
  • Fmoc-His-OH
  • 3-(2-Fluoro-4-nitrophenyl)-2-hydroxy-2-methylpropanoic acid
  • 2-Chloro-5-[(pyrrolidin-3-yl)methyl]pyridine
  • (2S)-4-(4-bromo-2-methoxyphenyl)butan-2-amine
  • 4-[(3-bromo-1-methyl-1H-pyrazol-5-yl)methyl]piperidine
  • 1-(4-chloro-2-methoxypyridin-3-yl)-N-methylcyclopropan-1-amine
  • 1-[1-(3-Bromo-5-methoxypyridin-4-yl)cyclopropyl]cyclopropan-1-amine
  • [1-(3-Bromothiophen-2-yl)-2-methylpropan-2-yl](methyl)amine
  • (1R)-1-(5-bromo-2-cyclopropylpyrimidin-4-yl)ethan-1-amine
  • 3-(2,5-Difluoro-4-nitrophenyl)-3,3-difluoropropanoic acid
  • O-[2-(2-bromo-6-fluorophenyl)-2-methylpropyl]hydroxylamine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.